- Home
- ABBV vs TSLA Comparison
ABBV vs TSLA Comparison
Compare ABBV & TSLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABBV | TSLA |
|---|---|---|
| Founded | 2012 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.5B | 1.5T |
| IPO Year | 2012 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ABBV | TSLA |
|---|---|---|
| Price | $221.50 | $405.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 32 |
| Target Price | $253.71 | ★ $405.47 |
| AVG Volume (30 Days) | 3.6M | ★ 41.6M |
| Earning Date | 04-29-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.39 | 0.13 |
| Revenue | $61,160,000,000.00 | ★ $94,827,000,000.00 |
| Revenue This Year | $11.87 | $10.82 |
| Revenue Next Year | $8.12 | $16.06 |
| P/E Ratio | ★ $568.14 | $3,168.46 |
| Revenue Growth | ★ 8.57 | N/A |
| 52 Week Low | $181.75 | $288.77 |
| 52 Week High | $244.81 | $498.83 |
Technical Indicators
Market Signals| Indicator | ABBV | TSLA |
|---|---|---|
| Relative Strength Index (RSI) | 55.96 | 48.80 |
| Support Level | $220.11 | $386.85 |
| Resistance Level | $230.91 | $414.07 |
| Average True Range (ATR) | 5.03 | 17.02 |
| MACD | 0.05 | -2.49 |
| Stochastic Oscillator | 61.27 | 41.02 |
Price Performance
Historical ComparisonAbout ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
About TSLA Tesla Inc.
Tesla is a vertically integrated battery electric vehicle automaker and developer of real-world artificial intelligence software, which includes autonomous driving and humanoid robots. The company has multiple vehicles in its fleet, which include a midsize sedan and crossover SUV in the entry-level luxury category, a luxury light truck, and a semitruck. Tesla also runs a robotaxi service in four US metropolitan areas. Global deliveries in 2025 were nearly 1.64 million vehicles. Additionally, the company sells batteries for stationary storage for residential and commercial properties, including utilities, solar panels, and solar roofs for energy generation. Tesla also owns a fast-charging network and a US auto insurance business.